StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.51+0.08 (+17.64%)

Close on Nov 18, 2026Market cap $17.07MP/E –Yield –

Pasithea Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pasithea Therapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.1× to 1.4×, with a median of 0.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.4
2025Dec 31, 20250.8×+0.6
2024Dec 31, 20240.2×−0.1
2023Dec 29, 20230.3×−0.1
2022Dec 30, 20220.4×−1.1
2021Dec 31, 20211.4×–

More Pasithea Therapeutics figures

See a number that looks wrong?